Xi'an, China – March 14, 2025– KINTAI BIOTECH INC. (hereafter "KINTAI"), a global leader in natural plant active ingredients, announced today that it has successfully delivered 100 kilograms of high-purity Dihydromyricetin (DHM) to its partner, the internationally renowned beauty and health group Beiersdorf AG. This collaboration not only deepens the strategic partnership between the two companies but also highlights KINTAI's core strengths in natural ingredient R&D, large-scale production, and international supply chain services, injecting innovative momentum into the global beauty and health industries.
Technological Breakthrough and Quality Commitment: Dihydromyricetin as the "Gold Standard"
Dihydromyricetin, a flavonoid compound known for its exceptional antioxidant, anti-inflammatory, and photoprotective properties, has gained significant attention in the premium skincare and functional health product markets in recent years. However, its extraction process is complex, and maintaining consistent purity and stability presents a significant challenge to suppliers in terms of technical capabilities and quality control.
The 100kg batch of Dihydromyricetin delivered by KINTAI boasts a purity of over 98%, setting a quality standard. The production process adheres strictly to EU ECOCERT organic certification and ISO 9001 quality management standards. Utilizing its self-developed "Supercritical Coupling Molecular Imprint Purification Technology," KINTAI has overcome the traditional industry challenges of low yield and high impurity retention, achieving full control across the entire production chain, from raw material selection and extraction to purification and final product testing. KINTAI's Dihydromyricetin exceeded expectations in batch consistency and active ingredient stability, providing crucial support for anti-aging and sensitive skin repair product lines.
From Order to Delivery: KINTAI's Global Service Capability Proven Again
As a VIP partner of Beiersdorf, KINTAI demonstrated its rapid response system and flexible supply chain management, completing the full delivery process-from demand confirmation and customized production to cross-border logistics-within 30 days. For this order, KINTAI also implemented a "green channel" service, assigning a dedicated technical team to work closely with Beiersdorf's R&D department, ensuring precise alignment with their formulation requirements regarding particle size, solubility, and stability.
"The successful completion of this 100kg order exemplifies our 'Custom Service for Key Clients' model," said KINTAI CEO Chen Jin Feng. "We not only provide standardized products but also strive to be a technical partner in our customers' value chains, helping brands gain a competitive edge through collaborative innovation."
Sustainability: Dual Commitment to Green Production and Ethical Sourcing
While expanding its production capacity, KINTAI continues to prioritize sustainability as a core strategy. The Dihydromyricetin supplied in this order is sourced from organic tea vines grown in the Wuling Mountains of China. The company's "farmer + cooperative + enterprise" closed-loop management model ensures both biodiversity protection and community economic benefits. In production, KINTAI employs heat recovery and zero wastewater discharge processes, reducing energy consumption by 40% compared to traditional methods and receiving the EcoVadis Bronze Award.
Industry Outlook: Exponential Growth in the Natural Active Ingredients Market
According to Grand View Research, the global natural cosmetics ingredients market surpassed $12 billion in 2023, with an annual compound growth rate of 8.3%. Dihydromyricetin, as a "super ingredient," is rapidly expanding beyond premium skincare into functional foods and medical auxiliary materials. Through collaborations with SGS institutions, KINTAI has finished 5 key tests for this ingredient and plans to launch a smart, large-scale production facility in 2027, further strengthening its position in the global supply chain.
About KINTAI Biotech
Founded in 2012, KINTAI Biotech specializes in the R&D, production, and solution provision of natural plant active ingredients. Its products span across the beauty, pharmaceutical, and health food sectors. The company operates an R&D center, third-party testing labs, GMP Certified facilities, and a warehouse network covering Europe and the US, serving over 50 global Fortune 500 clients. Looking ahead, KINTAI remains committed to its mission of "Natural Science, Empowering a Healthy Future" driving the industry towards greater efficiency, sustainability, and innovation.
If you are interested in our dihydromyricetin and other products, please feel free to contact us at sales@kintaibio.com.
